As an academic medical specialist and nephrologist-researcher, I am particularly interested in the pathogenesis and treatment of rare kidney disorders. In addition to trying to provide the best standard of care for all our patients, I have a specific interest in patients with rare renal tubular disorders. Fundamental research is focused at elucidating molecular mechanisms of kidney disease, in particular podocyte injury in rare glomerular diseases, which include deleterious intracellular pathways involving the calcium channel TRPC6. Ultimately, the goal is to identify molecular pathways that could serve as novel treatment targets, to be translated into new personalized treatment options for renal patients. This should ultimately help reduce renal damage, slow down renal function decline and prevent the progression to end stage renal disease. Clinical focus is on rare renal tubular disorders, which are often caused by dysfunction of renal tubular ion channels and transporters, that result in electrolyte and acid-base disorders. My efforts are aimed at improving diagnosis as well as identifying and implementing novel personalized treatment options to improve quality of life. Tom Nijenhuis (1977) is an internist-nephrologist and staff member of the department of Nephrology at the Radboudumc. He obtained his MD in 2001 and his PhD in 2006 with a thesis on renal calcium and magnesium channels in health and disease. He is member of the scientific board of the Dutch Federation for Nephrology (NfN) and the Young Nephrologists Committee of the International Society for Nephrology (ISN). Clinical and research efforts are embedded in the Radboudumc Expertise Center for Rare Kidney Disorders and the Radboudumc research theme Kidney Disorders.